Juan Hincapie-Castillo,
Assistant Professor
Department:
Pharmaceutical Outcomes & Policy
Business Phone:
(352) 273-5526
Business Email:
j.hincapie@ufl.edu
Teaching Profile
Courses Taught
2020-2021
PHA6268 Pharmacoepidemiology and Patient Safety
2020-2021
PHA7979 Advanced Research
2020-2021
PHA6971 Research for Master’s Thesis
2021
PHA6894 Introduction to Graduate Studies
2020-2021
PHA6910 Supervised Research
2019-2021
PHA5244 Prin Evid Based Prac
2020-2021
PHA6935 Selected Topics in Pharmacy
2021
PHA6936 Advanced Topics in Pharmaceutical Sciences
2021
PHA6937 Topics in Pharmaceutical Administration
2020-2021
PHA7980 Research for Doctoral Dissertation
2021
PHA6265 Introduction to Pharmaceutical Outcomes and Policy I
2021
PHA6940 Supervised Teaching
2020
PHA5945 Leadership for International Pharmacy Outreach Experience
2020
PHA5706L Intl Outreach Exper
2018-2019
PHA5226C Pt Safety and Quality
2015
PHA5737 Drugs and Society
2014-2015
PHA5742C Pro Commun Pharm Prac
2014
PHA5226 Evidence-Base Pharmcy
Research Profile
Open Researcher and Contributor ID (ORCID)
Publications
2024
Association between trajectories of prescription opioid use and risk of opioid use disorder and overdose among US nonmetastatic breast cancer survivors.
Breast cancer research and treatment.
204(3):561-577
[DOI] 10.1007/s10549-023-07205-6.
[PMID] 38191684.
2024
Computational phenotyping within electronic healthcare data to identify transgender people in the United States: A narrative review.
Pharmacoepidemiology and drug safety.
33(3)
[DOI] 10.1002/pds.5732.
[PMID] 38009550.
2024
Medications for Opioid Use Disorder and Mortality and Hospitalization Among People With Opioid Use-related Infections.
Epidemiology (Cambridge, Mass.).
35(1):7-15
[DOI] 10.1097/EDE.0000000000001681.
[PMID] 37820243.
2024
The Unseen Hand: AI-Based Prescribing Decision Support Tools and the Evaluation of Drug Safety and Effectiveness.
Drug safety.
47(2):117-123
[DOI] 10.1007/s40264-023-01376-3.
[PMID] 38019365.
2023
Complications in Using Real-World Data to Study the Health of People Who Use Drugs.
Epidemiology (Cambridge, Mass.).
34(2):259-264
[DOI] 10.1097/EDE.0000000000001564.
[PMID] 36722808.
2023
Enhancing active learning of medication errors in the PharmD curriculum through a multi-perspective video-based experience.
Currents in pharmacy teaching & learning.
15(3):258-265
[DOI] 10.1016/j.cptl.2023.03.009.
[PMID] 37029078.
2023
Mifepristone and the courts: The thread that could unravel regulation of drugs in the United States.
Pharmacoepidemiology and drug safety.
32(9):1049-1051
[DOI] 10.1002/pds.5642.
[PMID] 37278192.
2023
Mortality associated with bacterial and fungal infections and overdose among people with drug use diagnoses.
Annals of epidemiology.
87
[DOI] 10.1016/j.annepidem.2023.09.002.
[PMID] 37690738.
2023
Patterns of Cough Medication Prescribing among Patients with Chronic Cough in Florida: 2012-2021.
Journal of clinical medicine.
12(19)
[DOI] 10.3390/jcm12196286.
[PMID] 37834931.
2023
Pragmatic Model and Faculty Toolkit for PharmD Student Engagement in Social and Administrative Pharmacy Research.
American journal of pharmaceutical education.
87(5)
[DOI] 10.1016/j.ajpe.2023.02.006.
[PMID] 37288693.
2023
Trends in Prescribing of Non-steroidal Anti-inflammatory Medications in the US Ambulatory Care Setting From 2006 to 2016.
The journal of pain.
24(11):1994-2002
[DOI] 10.1016/j.jpain.2023.06.008.
[PMID] 37330160.
2023
Trends, characteristics, race, and ethnicity associated with nonadherence to antidepressants among breast cancer survivors with depression.
Journal of managed care & specialty pharmacy.
29(4):431-445
[DOI] 10.18553/jmcp.2023.29.4.431.
[PMID] 36989452.
2023
Using Joinpoint regression for drug utilization research: Tutorial and case study of prescription opioid use in the United States.
Pharmacoepidemiology and drug safety.
32(5):509-516
[DOI] 10.1002/pds.5606.
[PMID] 36813735.
2022
Buprenorphine Use Trends Following Removal of Prior Authorization Policies for the Treatment of Opioid Use Disorder in 2 State Medicaid Programs.
JAMA health forum.
3(6)
[DOI] 10.1001/jamahealthforum.2022.1757.
[PMID] 35977240.
2022
Changes in Prescribing by Provider Type Following a State Prescription Opioid Restriction Law.
Journal of general internal medicine.
37(8):1838-1844
[DOI] 10.1007/s11606-021-06966-4.
[PMID] 34236602.
2022
Co-utilization of opioids and nonbenzodiazepine hypnotic drugs in U.S. ambulatory care visits, 2006-2016.
Journal of the American Pharmacists Association : JAPhA.
62(2):468-474.e2
[DOI] 10.1016/j.japh.2021.10.020.
[PMID] 34799261.
2022
Dosing profiles of concurrent opioid and benzodiazepine use associated with overdose risk among US Medicare beneficiaries: group-based multi-trajectory models.
Addiction (Abingdon, England).
117(7):1982-1997
[DOI] 10.1111/add.15857.
[PMID] 35224799.
2022
Environmental scan of COVID-19 infection dashboards in the Florida public school system.
Frontiers in public health.
10
[DOI] 10.3389/fpubh.2022.925808.
[PMID] 35968490.
2022
Evaluation of Cough Medication Use Patterns in Ambulatory Care Settings in the United States: 2003-2018.
Journal of clinical medicine.
11(13)
[DOI] 10.3390/jcm11133671.
[PMID] 35806956.
2022
Medicare Bundled Payment Policy on Anemia Care, Major Adverse Cardiovascular Events, and Mortality among Adults Undergoing Hemodialysis.
Clinical journal of the American Society of Nephrology : CJASN.
17(6):851-860
[DOI] 10.2215/CJN.14361121.
[PMID] 35589388.
2022
Prescription Patterns of Adjuvant Pain Medications Following an Opioid Supply Restriction Law: An Interrupted Time Series Analysis.
Medical care.
60(6):432-436
[DOI] 10.1097/MLR.0000000000001719.
[PMID] 35315375.
2022
Reducing Health Disparities Through Achieving Pharmacoequity.
JAMA.
327(6):589-590
[DOI] 10.1001/jama.2021.24519.
[PMID] 35133419.
2022
Trends in the Management of Headache Disorders in US Emergency Departments: Analysis of 2007-2018 National Hospital Ambulatory Medical Care Survey Data.
Journal of clinical medicine.
11(5)
[DOI] 10.3390/jcm11051401.
[PMID] 35268492.
2021
A call to look beyond prescription opioid supply-side restrictions and include health equity when predicting opioid policy effectiveness.
Lancet regional health. Americas.
3
[DOI] 10.1016/j.lana.2021.100075.
[PMID] 36777402.
2021
A Mapping Literature Review of Medical Cannabis Clinical Outcomes and Quality of Evidence in Approved Conditions in the USA from 2016 to 2019.
Medical cannabis and cannabinoids.
4(1):21-42
[DOI] 10.1159/000515069.
[PMID] 34676348.
2021
A survey assessment of clinician perceptions of opioid supply and monitoring requirement policy changes.
Journal of opioid management.
17(4):337-342
[DOI] 10.5055/jom.2021.0666.
[PMID] 34533828.
2021
Association of US Food and Drug Administration Removal of Indications for Use of Oral Quinolones With Prescribing Trends.
JAMA internal medicine.
181(6):808-816
[DOI] 10.1001/jamainternmed.2021.1154.
[PMID] 33871571.
2021
Changes in Quantity of Opioids Dispensed following Florida’s Restriction Law for Acute Pain Prescriptions.
Pain medicine (Malden, Mass.).
22(8):1870-1876
[DOI] 10.1093/pm/pnab017.
[PMID] 33502536.
2021
Changes in Schedule II oral opioid volume dispensed in a private health plan following Florida’s Acute Pain Opioid Restriction Law.
Journal of managed care & specialty pharmacy.
27(6):779-784
[DOI] 10.18553/jmcp.2021.27.6.779.
[PMID] 34057389.
2021
Chronic Opioid Therapy Utilization Following an Acute Pain Prescription Supply Restriction Law: An Interrupted Time Series Analysis.
Pain physician.
24(6):417-424
[PMID] 34554682.
2021
Chronic Opioid Therapy: A Scoping Literature Review on Evolving Clinical and Scientific Definitions.
The journal of pain.
22(3):246-262
[DOI] 10.1016/j.jpain.2020.09.002.
[PMID] 33031943.
2021
Effects of hydrocodone rescheduling on opioid use outcomes: A systematic review.
Journal of the American Pharmacists Association : JAPhA.
61(2):e20-e44
[DOI] 10.1016/j.japh.2020.09.013.
[PMID] 33127312.
2021
Impact of Opioid Restrictions During a Critical Drug Shortage Period: Interrupted Time Series for Institutional Opioid Utilization.
Pain medicine (Malden, Mass.).
22(1):203-211
[DOI] 10.1093/pm/pnaa211.
[PMID] 32875327.
2021
Purchasing Drugs Abroad Among U.S. Cancer Survivors: Analysis of the National Health Interview Survey, 2011-2018.
American journal of preventive medicine.
60(5):e231-e234
[DOI] 10.1016/j.amepre.2020.10.017.
[PMID] 33358718.
2021
Real-World Fetal Exposure to Acne Treatments in the United States: A Retrospective Analysis from 2006 to 2015.
Drug safety.
44(4):447-454
[DOI] 10.1007/s40264-021-01053-3.
[PMID] 33683646.
2021
Trends in Sexually Transmitted Infections in United States Ambulatory Care Clinics from 2005-2016.
Journal of clinical medicine.
11(1)
[DOI] 10.3390/jcm11010071.
[PMID] 35011812.
2021
Trends in Use of Prescription Nonsteroidal Anti-inflammatory Medications Before vs After Implementation of a Florida Law Restricting Opioid Prescribing for Acute Pain.
JAMA network open.
4(6)
[DOI] 10.1001/jamanetworkopen.2021.13383.
[PMID] 34115125.
2020
Changes in Opioid Use After Florida’s Restriction Law for Acute Pain Prescriptions.
JAMA network open.
3(2)
[DOI] 10.1001/jamanetworkopen.2020.0234.
[PMID] 32108887.
2020
Comparative effectiveness of risk mitigation strategies to prevent fetal exposure to mycophenolate.
BMJ quality & safety.
29(8):636-644
[DOI] 10.1136/bmjqs-2019-010098.
[PMID] 31649165.
2020
Socioeconomic and Demographic Characteristics of US Adults Who Purchase Prescription Drugs From Other Countries.
JAMA network open.
3(6)
[DOI] 10.1001/jamanetworkopen.2020.8968.
[PMID] 32579194.
2019
Development of a predictive model for drug-associated QT prolongation in the inpatient setting using electronic health record data.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
76(14):1059-1070
[DOI] 10.1093/ajhp/zxz100.
[PMID] 31185072.
2018
Clinical utility and perils of prescription drug monitoring program-based alert systems.
Pain.
159(4):804-805
[DOI] 10.1097/j.pain.0000000000001157.
[PMID] 29557901.
2018
Prevalence, Time Trends, and Utilization Patterns of Psychotropic Polypharmacy Among Pediatric Medicaid Beneficiaries, 1999-2010.
Psychiatric services (Washington, D.C.).
69(8):919-926
[DOI] 10.1176/appi.ps.201700260.
[PMID] 29879872.
2017
Acute Kidney Injury Risk Associated With Piperacillin/Tazobactam Compared With Cefepime During Vancomycin Therapy in Hospitalised Patients: a Cohort Study Stratified By Baseline Kidney Function
International Journal of Antimicrobial Agents.
50(1):63-67
[DOI] 10.1016/j.ijantimicag.2017.02.023.
2017
Bariatric Surgery and Risk for Perinatal Complications.
JAMA surgery.
152(6):607-608
[DOI] 10.1001/jamasurg.2017.0113.
[PMID] 28329328.
2017
Consistency of psychotropic drug-drug interactions listed in drug monographs.
Journal of the American Pharmacists Association : JAPhA.
57(6):698-703.e2
[DOI] 10.1016/j.japh.2017.07.008.
[PMID] 28844584.
2017
Development and validation of a complexity score to rank hospitalized patients at risk for preventable adverse drug events.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
74(23):1970-1984
[DOI] 10.2146/ajhp160995.
[PMID] 29167139.
2017
Development and validation of a Complexity-Score to rank hospitalized patients at risk for preventable adverse drug events
American Journal of Health-System Pharmacy.
74(23):1970-1984
2017
Evaluating the effects of diffused lavender in an adult day care center for patients with dementia in an effort to decrease behavioral issues: a pilot study.
Journal of drug assessment.
6(1):1-5
[DOI] 10.1080/21556660.2016.1278545.
[PMID] 28265482.
2017
Prevalence of Psychotherapy Surrounding Initiation of Psychotropic Polypharmacy in the Medicaid-Insured Population, 1999-2010.
Psychiatric services (Washington, D.C.).
68(11):1120-1126
[DOI] 10.1176/appi.ps.201600511.
[PMID] 28669287.
2017
Use of lithium in patients with unipolar depression.
The lancet. Psychiatry.
4(9):662-663
[DOI] 10.1016/S2215-0366(17)30317-6.
[PMID] 28853406.
2014
Considerations for the appropriate use of skeletal muscle relaxants for the management of acute low back pain.
P & T : a peer-reviewed journal for formulary management.
39(6):427-35
[PMID] 25050056.
2012
Ototopical neomycin exposure in children with nonintact tympanic membranes.
The Laryngoscope.
122(11):2529-32
[DOI] 10.1002/lary.23554.
[PMID] 22965584.
Grants
Jan 2020
– Feb 2021
Leveraging social media data for evaluation of drug use trends after opioid policies
Role: Principal Investigator
Funding: AMER ASSO OF COL OF PHARMACY
Sep 2018
ACTIVE
University of Florida Resource Center for Minority Aging Research
Role: Project Manager
Funding: NATL INST OF HLTH NIA
Contact Details
Phones:
- Business:
- (352) 273-5526
Emails:
- Business:
- j.hincapie@ufl.edu
Addresses:
- Business Mailing:
-
PO Box 100496
GAINESVILLE FL 32610 - Business Street:
-
1225 CENTER DR
HPNP 2338
GAINESVILLE FL 326103007